Svedung Wettervik Teodor, Hånell Anders, Ahlgren Kerstin M, Hillered Lars, Lewén Anders
Department of Medical Sciences, Section of Neurosurgery, Uppsala University, 751 85, Uppsala, Sweden.
Department of Surgical Sciences, Uppsala University, 751 85, Uppsala, Sweden.
Neurocrit Care. 2025 Feb;42(1):222-231. doi: 10.1007/s12028-024-02080-5. Epub 2024 Jul 31.
Brain energy metabolism is often disturbed after acute brain injuries. Current neuromonitoring methods with cerebral microdialysis (CMD) are based on intermittent measurements (1-4 times/h), but such a low frequency could miss transient but important events. The solution may be the recently developed Loke microdialysis (MD), which provides high-frequency data of glucose and lactate. Before clinical implementation, the reliability and stability of Loke remain to be determined in vivo. The purpose of this study was to validate Loke MD in relation to the standard intermittent CMD method.
Four pigs aged 2-3 months were included. They received two adjacent CMD catheters, one for standard intermittent assessments and one for continuous (Loke MD) assessments of glucose and lactate. The standard CMD was measured every 15 min. Continuous Loke MD was sampled every 2-3 s and was averaged over corresponding 15-min intervals for the statistical comparisons with standard CMD. Intravenous glucose injections and intracranial hypertension by inflation of an intracranial epidural balloon were performed to induce variations in intracranial pressure, cerebral perfusion pressure, and systemic and cerebral glucose and lactate levels.
In a linear mixed-effect model of standard CMD glucose (mM), there was a fixed effect value (± standard error [SE]) at 0.94 ± 0.07 (p < 0.001) for Loke MD glucose (mM), with an intercept at - 0.19 ± 0.15 (p = 0.20). The model showed a conditional R at 0.81 and a marginal R at 0.72. In a linear mixed-effect model of standard CMD lactate (mM), there was a fixed effect value (± SE) at 0.41 ± 0.16 (p = 0.01) for Loke MD lactate (mM), with an intercept at 0.33 ± 0.21 (p = 0.25). The model showed a conditional R at 0.47 and marginal R at 0.17.
The established standard CMD glucose thresholds may be used as for Loke MD with some caution, but this should be avoided for lactate.
急性脑损伤后,脑能量代谢常受到干扰。目前采用脑微透析(CMD)的神经监测方法基于间歇性测量(每小时1 - 4次),但如此低的频率可能会遗漏短暂但重要的事件。解决方案可能是最近开发的洛克微透析(MD),它可提供葡萄糖和乳酸的高频数据。在临床应用之前,洛克微透析在体内的可靠性和稳定性仍有待确定。本研究的目的是验证洛克微透析与标准间歇性CMD方法的相关性。
纳入4只2 - 3个月大的猪。给它们植入两根相邻的CMD导管,一根用于标准间歇性评估,另一根用于连续(洛克微透析)评估葡萄糖和乳酸。标准CMD每15分钟测量一次。连续洛克微透析每2 - 3秒采样一次,并在相应的15分钟间隔内求平均值,以便与标准CMD进行统计比较。通过静脉注射葡萄糖和颅内硬膜外球囊充气诱导颅内压、脑灌注压以及全身和脑葡萄糖及乳酸水平的变化。
在标准CMD葡萄糖(毫摩尔)的线性混合效应模型中,洛克微透析葡萄糖(毫摩尔)的固定效应值(±标准误差[SE])为0.94±0.07(p < 0.001),截距为 - 0.19±0.15(p = 0.20)。该模型的条件R为0.81,边际R为0.72。在标准CMD乳酸(毫摩尔)的线性混合效应模型中,洛克微透析乳酸(毫摩尔)的固定效应值(±SE)为0.41±0.16(p = 0.01),截距为0.33±0.21(p = 0.25)。该模型的条件R为0.47,边际R为0.17。
已确立的标准CMD葡萄糖阈值在一定程度上可谨慎用于洛克微透析,但对于乳酸应避免这样做。